Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DIscontinuation of Anticoagulation With Intensive Rhythm MONitoring CompareD With Continuous Anticoagulation in Post-ablation Patients With Atrial Fibrillation: A Randomized Controlled Trial

NCT06871228 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06871228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DIscontinuation of Anticoagulation With Intensive Rhythm MONitoring CompareD With Continuous Anticoagulation in Post-ablation Patients With Atrial Fibrillation: A Randomized Controlled Trial
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 5, 2025
Completion date
December 31, 2029
Enrollment
4,100 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)